Skip to main content
Y

Yzybio

YZY Bio develops bispecific antibodies that target multiple tumor antigens simultaneously, enhancing the precision of cancer treatment. This approach aims to improve therapeutic efficacy and reduce off-target effects in oncology patients.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • YZY Bio develops bispecific antibodies that target multiple tumor antigens simultaneously, enhancing the precision of cancer treatment. This approach aims to improve therapeutic efficacy and reduce off-target effects in oncology patients.
This profile is AI-generated and may contain inaccuracies.